Search Results

Warnings Regarding Nuclear Cardiac Stress Test Agents Issued By The FDA December 10, 2013 The U.S. Food and Drug Administration (FDA) has issued a warning about health risks that are associated with the use of certain medications given to patients during cardiac nuclear stress tests. The Drug Injury Attorneys with Ferrer Poirot Feller Daniel explain officials have stated patients who are given dosages of Lexiscan (regadenoson) (more...)